NDC 0093-4175
Cephalexin 125 mg per 5 mL powder, for suspension
On the label: Teva Pharmaceuticals USA, Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Teva Pharmaceuticals USA, Inc. names for other drugs.
Recalls
- Aug 24, 2020 · Class II · Teva Pharmaceuticals USA
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
Lots: Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021; 30310313A, Exp. 06/2021; b) 30309861A, Exp. 08/2020; 30310335A, Exp. 06/2021.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cephalexin: every company that makes it
- Form
- powder, for suspension, oral
- Strength
- 125 mg per 5 mL
- Approval
- ANDA ANDA062703
- On the market since
- Sep 30, 1990
- Package NDCs
0093-4175-730093-4175-74- Official label
- DailyMed (National Library of Medicine), updated Sep 2, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?